Please provide your email address to receive an email when new articles are posted on . Inferior vena cava filters are recommended for temporary use to prevent pulmonary embolism when anticoagulation ...

SILVER SPRING, Md., Dec. 21, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration authorized marketing of the first laser-based device for the removal of Inferior Vena Cava (IVC) filters.

First use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter Only FDA-cleared solution for ...

Please provide your email address to receive an email when new articles are posted on . An excimer laser sheath successfully removed inferior vena cava filters with low complication rates, according ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window FDA approved the ...

The US Food and Drug Administration (FDA) has cleared for marketing the Philips CavaClear Laser Sheath, the first laser-based device to facilitate removal of inferior vena cava (IVC) filters when ...

Use of inferior vena cava (IVC) filters declined substantially over a recent 8-year period, and while retrieval rates went up in that time, just one in seven indwelling filters were retrieved in a ...

Inferior vena cava (IVC) filters are often necessary to capture blood clots before they travel to the heart or lungs. But all too often, IVC filters are left in place long after they are needed, ...